Valuation: Balaxi Pharmaceuticals Limited

Market Cap 1.15B 12.16M 10.86M 10.03M 9.09M 17.01M 17.29M 121M 47.79M 605M 45.64M 44.67M 1.91B P/E 2025
14.1x
P/E 2026 61.1x
Enterprise Value 1.57B 16.49M 14.73M 13.6M 12.33M 23.06M 23.45M 164M 64.81M 820M 61.89M 60.57M 2.59B EV / Sales 2025
1.16x
EV / Sales 2026 0.47x
Free-Float
90.84%
Yield 2025 *
-
Yield 2026 -
1 day-0.43%
1 week-5.34%
Current month-8.21%
1 month-8.85%
3 months-14.37%
6 months-23.96%
Current year-22.18%
1 week 19.16
Extreme 19.16
22.35
1 month 19.16
Extreme 19.16
23.49
Current year 15.2
Extreme 15.2
29.9
1 year 15.2
Extreme 15.2
43.85
3 years 15.2
Extreme 15.2
151.45
5 years 15.2
Extreme 15.2
151.45
10 years 2.58
Extreme 2.58
216.04
Manager TitleAgeSince
Chief Executive Officer 56 04/05/2017
Director of Finance/CFO - 20/05/2021
Compliance Officer - 25/03/2026
Director TitleAgeSince
Chairman 56 04/05/2017
Director/Board Member 54 -
Director/Board Member 44 04/05/2017
Change 5-day change 1-year change 3-year change Capi.($)
-0.43%-5.34%-51.69%-74.83% 12.16M
-2.54%+1.31%+55.10%+120.84% 1,135B
-1.42%+3.23%+37.07%+74.26% 636B
+0.16%+0.08%+25.14%+97.36% 505B
-0.31%+3.09%+43.92%+64.55% 378B
-1.34%-0.47%+66.63%+40.56% 358B
-0.68%+2.65%+22.46%+51.48% 295B
-1.20%+3.04%+2.62%+26.97% 266B
-1.79%+1.57%+49.97%+60.87% 237B
-0.73%-0.10%+29.24%+101.19% 193B
Average -0.64%+1.42%+28.05%+56.32% 400.44B
Weighted average by Cap. -0.26%+2.66%+40.99%+82.13%

Financials

2025 2026
Net sales 2.93B 30.82M 27.52M 25.42M 23.04M 43.11M 43.82M 306M 121M 1.53B 116M 113M 4.83B 2.7B 28.46M 25.42M 23.48M 21.28M 39.81M 40.47M 283M 112M 1.42B 107M 105M 4.46B
Net income 251M 2.64M 2.36M 2.18M 1.97M 3.69M 3.75M 26.22M 10.38M 131M 9.91M 9.7M 414M 14.17M 149K 133K 123K 112K 209K 212K 1.48M 587K 7.42M 560K 548K 23.4M
Net Debt 127M 1.34M 1.2M 1.11M 1M 1.87M 1.91M 13.3M 5.27M 66.65M 5.03M 4.92M 210M 411M 4.33M 3.87M 3.57M 3.24M 6.06M 6.16M 42.99M 17.02M 215M 16.25M 15.91M 679M
Projected Income Statement - Annual - Balaxi Pharmaceuticals Limited
Logo Balaxi Pharmaceuticals Limited
Balaxi Pharmaceuticals Limited is an India-based company. The Company operates as an intellectual property right (IPR)-based pharmaceutical company. The Company primarily operates in frontier markets across the Americas, Africa and the Caribbean islands. The Company is focusing on frontier markets, with a growing portfolio of drugs across multiple therapeutic segments. It is engaged in International Wholesale Distribution of Pharmaceuticals. The Company’s products include Anti-biotic, Analgesic, Medical Device, Vitamins, Anti-Malaria, Erectile Dysfunction, Hypertension, Anti-Asthma, Steroid, Anti-Helminthic, Anti-Ulcer, Hygiene, Anticholinergic, Dietary Supplement, Diuretic, Hormone, Anti-Emetic, Bronchodilator, Local Anesthetic, Anemia, Anti-Diarrhea, Antihistamine, Hypotension, Antacid, Anti-Tuberculosis, Insect Repellents, and Laxative. Its Boadent brand includes anticavity dental toothpaste. Its subsidiaries are Balaxi Global DMCC, Dubai and Balaxi healthcare Ecuador.
Employees
500
Date Price Change Volume
23/10/26 ₹20.91 -0.43% 40,139
22/10/26 ₹21.00 -0.47% 62,006
21/10/26 ₹21.10 -3.03% 23,032
19/10/26 ₹21.76 -1.49% 19,900
16/10/26 ₹22.09 -0.18% 13,444
  1. Stock Market
  2. Stocks
  3. BALAXI Stock